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1. Introduction 
Human T-lymphocytes bind sheep erythrocytes 
(SRBC) under stringent in vitro conditions to form 
rosette-shaped figures when viewed under a micro- 
scope [l-5]. Although the phenomenon has no known 
in vivo consequences it has been an extremely useful 
marker of human T-cells and an indicator of matura- 
tion. The binding appears to be the consequence of
the presence of specific glycoproteins on the lympho- 
cyte surface which have a selective affinity for a fetuin- 
like ~ycopept~de onthe sheep erythrocyte membr~e 
[6-91. Peptide hormones ynthesized by thymic epi- 
thelial cells have been shown to induce its biosynthesis 
[ 10,111, but very little is known regarding the molec- 
ular events underly~g the induction process or the 
regulation of the biosynthetic process once it is ini- 
tiated. These experiments are the first in a series 
designed to elucidate the regulatory mechanism of
thymic hormones on expression of erythrocyte recep- 
tor. Using the experimental model in 1121 we demon- 
strate that the biosynthesis of the erythrocyte binding 
protein is under a transc~ptional ~ontrol”me~hanism 
and once the genome of this protein is turned on 
during the maturation process, it continues to express 
without any further hormonal requirement. 
2. Materials and methods 
2 .I. Isolation of horns lymphocytes 
Lymphocytes were obtained from normal abora- 
tory personnel by centrifugation of fresh heparinized 
venous blood grout Fico~-Hypaque ~LSM-Bionetics, 
Kensington,MD) [13]. 
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2 2. Sheep erythrocyte binding by ~-iymphocytes 
(E-rosette formation) 
The quantitation of T-lymphocytes by their inter- 
action with SRBC to form E-rosettes was performed 
by a modification of the method in [3]. Each proce- 
dure was performed in triplicate. 
2.3. T~ps~~a~on of lymphocytes 
Lymphocyte t~ps~~ation was done as in [ 14,151. 
Fresh trypsin solution (Sigma, St Louis MO) 1 mg/ml 
was prepared aily by reconstitution i  Dulbecco’s 
phosphate-buffered saline (D-PBS) (Gibco, Grand 
Island NY) and pre-warmed at37°C immediately prior 
to use. Mononuclear cells, separated as described, were 
washed twice in Hank’s balanced salt solution (HBSS} 
(Gibco) with no added fetal calf serum (FCS) (Gibco) 
and resuspended in 10 ml pre-warmed trypsin solu- 
tion. After incubation for 5 min in 37’C water bath, 
the cell suspension was placed in ice for an additional 
5 min before washing twice with cold D-PBS. The 
trypsinized lymphocytes were resuspended in HBSS 
without FCS at 7.5 X 1 06/ml for determination of the 
proportion of lymphocytes retaining their SRBC 
receptors by standard E-rosette formation. Viability 
was assessed by trypan blue exclusion. 
2.4. Culture conditions 
Cells were incubated at RPMI 1640 (Flow Lab., 
McLean VA) without serum at 37°C in an atmosphere 
of 5% CO% and air on a rocking platform. 
2.5 . Metabolic b focking agents 
The following agents were added to trypsinized 
lymphocytes for final concentration of: puromycin 5, 
IO and 20 fig/ml (Boeh~nger M~~eirn, Indianapolis 
IN); cycloheximide 10 and 20 @g/ml (Nutritional Bio- 
295 
Volume 121, number 2 FEBS LETTERS December 1980 
them, Cleveland OH); actinomycin-D, 0.1 , 1,5,10 
and 20 pg/ml (Sigma); cordycepin (Sigma) 50 yg/ml. 
Following incubation the cells were washed, their 
viability assessed by trypan blue exclusion, and pre- 
pared for the E-rosette assay. 
3. Results 
3 .l . Recovev of sheep erythrocytes binding capacity 
following trypsinization 
Trypsinization of normal human peripheral blood 
lymphocytes reduced the number of lymphocytes 
capable of forming E-rosettes, e.g., binding erythro- 
cytes, from the pre-treatment levels of 55-65% down 
to 2-8%. The viability of the trypsinized cells 
remained >97%. 
Fig.1 illustrates the recovery of erythrocyte binding 
capacity following trypsinization while maintained in 
vitro in RPM1 1640. The % of E-rosette forming cells 
returned to the pre-trypsin level after 9 h incubation. 
This regeneration curve is extremely reproducible. 
3.2. Effect of metabolic inhibitors on recovery of 
erythrocyte binding capacity 
Table 1 summarizes the effect of metabolic inhib- 
itors on the regeneration of erythrocyte binding pro- 
tein when assessed after 9 h incubation. These data 
show the results of 1 dose for each inhibitor, but com- 
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Fig.1. Regeneration of sheep erythrocyte binding protein fol- 
lowing trypsinization. The values indicate observed % (*SD) 
of rosettes formed over untrypsinized control after different 
time intervals of incubation at 37°C in 5% CO, and air. The 
viability of these cells after 9 h incubation is -97%. Details 
of the experiment are in section 2. 
Table 1 
Effect of metabolic inhibitors on regeneration of Erosettes 
Reagent % E-rosettes 
Non-trypsinized Trypsinized + 9 h 
incubation 
None 
Puromycin 
10 wg/ml 
58.3 + 4.1 55.0 f. 2.3 
57.1 f 3.8 6.0 f 2.1 
Cycloheximide 
100 pg/ml 55.3 + 0.7 4.1 r 0.9 
Actinomycin-D 
1 pgglml 57.3 f 0.9 4.0 + 2.1 
Effect of transcriptional and translational inhibitors on recov- 
ery of erythrocyte binding protein following trypsiniration. 
The concentration of inhibitors used in the experiment are at 
optimum level. The data represent observed % (*SD) rosettes 
over untreated controls 
Cyclohexlmlde 
Tim0 (Hour) 
Tim0 (Hour) 
Fig.2. (A,B) Effect of metabolic inhibitors on regeneration of 
sheep erythrocyte binding protein following trypsinization. 
The concentration of the inhibitors used are at optimum level. 
The inhibitors are added at different times after incubation as 
indicated by the arrow and the cells were further incubated 
for a total of 9 h. Values indicate the observed % (*SD) 
rosettes. Plotted values with no error bars indicate an SD < 1. 
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parable results were obtained with all doses utilized. 
The viability of these cells in the presence of inhibitors 
remains high, generally X5%. The results indicate the 
recovery of erythrocyte binding capacity is dependent 
on both DNA-dependent mRNA synthesis and pro- 
tein synthesis. 
Fig.2A illustrates the time course of recovery in the 
presence or absence of either actinomy@-D or cyclo- 
hexlmide. Recovery again was complete by 9 h in the 
untreated cultures. The metabolic blockers completely 
abrograted the development of erythrocyte binding 
capacity when added to trypsinized cells. Actinomy- 
cinD had no effect on the binding capacity of non- 
trypsinized cells over the 12 h duration of this experi- 
ment. 
Fig.2B illustrates the effect of actinomycin-D 
(1 pg/ml) or cordycepin triphosphate (50 pg/ml) when 
added to cultures after 3 or 6 h incubation. No addi- 
tional lymphocytes acquire rosetting capacity once 
these inhibitors are added. 
4. Discussion 
Normal human T-lymphocytes, deprived of their 
erythrocyte binding capacity by trypsinization, will 
regain that capacity if permitted to synthesize mRNA 
and protein. No signal has to be received from outside 
the cell for this to be accomplished. Protein synthesis 
in most eukaryotic ells is regulated at the transla- 
tional level using pre-synthesized long-lived mRNA 
[ 16,171. In present experiments he recovery of eryth- 
rocyte binding proteins are accomplished by DNA- 
dependent mRNA synthesis without any exogenous 
hormonal influence. These results uggest that thymic 
hormones are important only in the initial induction 
step and once the cells have undergone differentiation, 
the genome for erythrocyte binding protein’appears 
derepressed permanently. 
The use of 5% human serum in the incubation medi- 
um in [ 121 makes it impossible to rule out a possible 
role for thymic hormones in the recovery process, but 
does not negate their conclusions regarding the need 
for nascent mRNA synthesis. 
When actinomycin-D is added at the period (fig.3) 
that allows the time normally required for mRNA to 
be synthesized and transported into the cytoplasm, 
the regeneration of erythrocyte binding protein is still 
inhibited. In [ 181 were reported two classes of poly(A) 
mRNA in resting human lymphocytes, astable class, 
which has half-life -20 h and a labile class with half- 
life of <l h. 70% of the total mRNA in resting human 
lymphocytes is of short-lived type el h). Studies of 
the turnover of poly(A) mRNA for specific surface 
proteins uch as erythrocyte binding protein have not 
been performed. A direct interference of actinomy- 
tin-D on the binding of sheep erythrocytes i  ruled 
out since it had no effect on non-trypsinized cells cul- 
tured in its presence (fig.2). It is possible that eryth- 
rocyte binding protein continuously sheds and regen- 
erates as a normal process. These data indicate that no 
shedding of the erythrocyte binding protein occurs in 
actinomycin-D blocked cells. Whether shedding occurs 
in non-blocked cells cannot be ascertained from this 
data, but it will be of interest o determine whether 
removal of the protein leads to new synthesis and, if 
so, whether the process is regulated at the transcrip- 
tional or translational level. 
The use of normal peripheral blood Tcells pre- 
cludes conclusions regarding the half-life of the 
mRNA and hence of the level of regulatory control. 
Many subsets of T-cells, all binding sheep erythro- 
cytes, are present in this population and they may 
well have different biological time clocks when it 
comes to the biosynthesis of surface membrane pro- 
teins. Furthermore, these polyclonal cells are not syn- 
chronized. Consequently the observations (fig.3) that 
actinomycin-D or cordycepin arrest he recovery of 
further rosetting capacity by these cell populations i  
subject o alternative interpretations. An ongoing 
study of this matter in our laboratory utilizing a thy- 
mic hormone-inducible monoclonal leukemic ell line 
should facilitate the elucidation of these regulatory 
processes. 
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